Literature DB >> 19628749

Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.

Kunihiro Kiyosaki1, Chisato Nakada, Naoki Hijiya, Yoshiyuki Tsukamoto, Keiko Matsuura, Kazuo Nakatsuka, Tsutomu Daa, Shigeo Yokoyama, Masamoto Imaizumi, Masatsugu Moriyama.   

Abstract

PURPOSE: The purpose of this study was to detect mutation of the p53 gene, to assess its relationship with p53 or p21(WAF1/CIP1) expression, and to evaluate the correlation between p53 mutation or p21(WAF1/CIP1) expression and clinicopathologic findings in sebaceous carcinoma of the eyelid.
METHODS: Fifteen conventional paraffin-embedded samples of sebaceous carcinoma of the eyelid were analyzed. Using the single-strand conformation polymorphism technique, the authors sequenced coding exons 5-8 of the p53 gene. The expression of p53 and p21(WAF1/CIP1) protein was analyzed by immunohistochemistry.
RESULTS: In 10 of the 15 cases (66.7%), point mutations were detected in the p53 gene. CC to TT double-base changes (tandem mutations), which are known to be induced only by UV, were not detected in any of the mutations. Correlations between p53 mutation and expression were found to be statistically significant (P = 0.007). There was no significant correlation between p53 mutation and clinicopathologic findings or p21(WAF1/CIP1) expression. However, there was a significant inverse correlation between p21(WAF1/CIP1) expression and presence of lymph node metastasis (P = 0.007).
CONCLUSIONS: Among human cancers, sebaceous carcinoma of the eyelid may be one of those showing most frequent mutation of the p53 gene, which may not be caused by exposure to UV. p21(WAF1/CIP1) downregulation may be associated with lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628749     DOI: 10.1167/iovs.09-4127

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  p53 staining correlates with tumor type and location in sebaceous neoplasms.

Authors:  Sara C Shalin; Aniket Sakharpe; Stephen Lyle; Dina Lev; Eduardo Calonje; Alexander J Lazar
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

2.  Villous Sebaceous Adenoma Arising from the Caruncular Surface Squamous Epithelium.

Authors:  Frederick A Jakobiec; Paula Cortes Barrantes; Tatyana Milman
Journal:  Ocul Oncol Pathol       Date:  2020-03-10

3.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.

Authors:  Tatsuya Yunoki; Tetsushi Hirano; Yoshiaki Tabuchi; Yukihiro Furusawa; Misako Torigoe; Takahiko Nakajima; Johji Imura; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2019-09-30       Impact factor: 2.031

Review 4.  The molecular genetics of eyelid tumors: recent advances and future directions.

Authors:  Tatyana Milman; Steven A McCormick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-30       Impact factor: 3.117

5.  Expression of p16 and p53 in Intraepithelial Periocular Sebaceous Carcinoma.

Authors:  W Robert Bell; Kamaljeet Singh; Anand Rajan Kd; Charles G Eberhart
Journal:  Ocul Oncol Pathol       Date:  2015-09-18

Review 6.  The role of genetics in the pathogenesis of periocular cutaneous neoplasms: implications for targeted therapy.

Authors:  Nahyoung Grace Lee; Leo A Kim; Suzanne K Freitag
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

7.  Periocular sebaceous gland carcinoma: A comprehensive review.

Authors:  Kaustubh Mulay; Ekta Aggarwal; Valerie A White
Journal:  Saudi J Ophthalmol       Date:  2013-07

8.  Early onset sebaceous carcinoma.

Authors:  Dongjin Sung; Sara A Kaltreider; Federico Gonzalez-Fernandez
Journal:  Diagn Pathol       Date:  2011-09-05       Impact factor: 2.644

9.  Immunohistochemical expression of X-linked inhibitor of apoptosis in eyelid sebaceous gland carcinoma predicts a worse prognosis.

Authors:  Perumal Jayaraj; Seema Sen; P S Dhanaraj; Romika Jhajhria; Shalu Singh; Vijay Kumar Singh
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

10.  c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis.

Authors:  Denny L Cottle; Kai Kretzschmar; Pawel J Schweiger; Sven R Quist; Harald P Gollnick; Ken Natsuga; Satoru Aoyagi; Fiona M Watt
Journal:  Cell Rep       Date:  2013-02-09       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.